GlassScriptPhysician profile
Elizabeth Spence
NPI 1518284629
$910.44
in general payments reported to CMS, 2019-2025
22 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $125 · 2023: $370 · 2024: $162 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $207.31 | 2021-2023 | Qelbree |
| Exact Sciences Corporation | $97.34 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $73.10 | 2023-2025 | |
| Viiv Healthcare Company | $71.65 | 2023-2025 | Apretude |
| Lilly USA, LLC | $52.73 | 2021-2025 | Mounjaro |
| Corium, LLC | $50.91 | 2022-2023 | Azstarys |
| Glaxosmithkline, LLC. | $41.77 | 2022-2024 | Shingrix, Rotarix, Pediarix |
| Corcept Therapeutics | $38.13 | 2025 | Korlym |
| Abbott Laboratories | $37.16 | 2023 | Freestyle Libre, Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $29.53 | 2023-2025 | Breztri, Fasenra |
| Amgen INC. | $27.74 | 2023 | Repatha, Otezla |
| Phadia US INC. | $20.31 | 2024 | Immunocap |
| Gilead Sciences, INC. | $18.79 | 2023 | |
| Alkermes, INC. | $18.71 | 2021 | |
| Ironshore Pharmaceuticals INC. | $18.42 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.37 | 2021 | |
| Organon LLC | $16.30 | 2021 | |
| Sanofi Pasteur INC. | $15.71 | 2023 | |
| Novo Nordisk INC | $14.99 | 2024 | Rybelsus |
| Cranial Technologies, INC | $14.65 | 2025 | Doc Band |
| Becton, Dickinson and Company | $13.65 | 2024 | Venclose Maven Catheter |
| Abbvie INC. | $13.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Spence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.